Почетна › Рак (сите типови) › Орегон › Portland
Клинички испитувања за Рак (сите типови) во Portland, OR
34 студии за Рак (сите типови) бараат учесници на локации во и околу Portland (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Се регрутираФаза 2
- Providence Portland Medical Center /ID# 277727, Portland
A Study of ASP3082 in Adults With Advanced Solid Tumors
Се регрутираФаза 1
- Oregon Health and Science University, Portland
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Се регрутираФаза 1
- Oregon Health & Science University, Portland
A Study of PHN-012 in Patients With Advanced Solid Tumors
Се регрутираФаза 1
- PHN-012-001 Site, Portland
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Се регрутираФаза 3
- Investigative Site, Portland
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Се регрутираФаза 2/3
- OHSU Center for Health & Healing 1, Portland
- Oregon Health and Science University, Portland
- OSHU Center for Health and Healing 2, Portland
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Се регрутираФаза 3
- Oregon Health and Science University /ID# 280071, Portland
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Се регрутираФаза 2
- Providence Health & Services, Portland
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Се регрутираФаза 2/3
- Providence Portland Medical Center, Portland
- Oregon Health and Science University OHSU, Portland
Connect for Cancer Prevention Study (Connect)
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Kaiser Permanente Northwest, Portland
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Се регрутираФаза 1/2
- Oregon Health and Science University ( Site 3004), Portland
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Се регрутираФаза 1/2
- Oregon Health and Science University /ID# 272282, Portland
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Се регрутираФаза 1
- Providence Cancer Institute, Portland
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Се регрутираФаза 3
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
- Kaiser Permanente Interstate Medical Office Central, Portland
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Се регрутираФаза 1
- Providence Portland Medical Center, Portland
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
Се регрутираНабљудувачка студија
- Oregon Health and Science University, Portland
Project: Every Child for Younger Patients With Cancer
Се регрутираНабљудувачка студија
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Oregon Health and Science University, Portland
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Се регрутираФаза 2
- Oregon Health and Science University, Portland
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Се регрутираФаза 3
- Legacy Good Samaritan Hospital and Medical Center, Portland
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- и уште 2
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
Се регрутираФаза 2
- OHSU Knight Cancer Institute, Portland
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Се регрутираФаза 2
- Northwest Cancer Specialists /ID# 275151, Portland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- Providence Cancer Institute Franz Clinic, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Се регрутираФаза 2
- Oregon Health and Science University, Portland
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Се регрутираФаза 1
- GSK Investigational Site, Portland
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Се регрутира
- VA Portland Health Care System, Portland, OR, Portland
Galleri® in the Medicare Population.
Се регрутираДобредојдени се здрави волонтери
- OHSU CEDAR Clinical Trials Portland, Portland
- OHSU CEDAR Clinical Trials Richmond, Portland
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Се регрутираФаза 2
- Oregon Health & Science Institute (OHSU), Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Се регрутираФаза 1/2
- Providence Neurological Specialties West, Portland
Beat Childhood Cancer Specimen Banking and Data Registry
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Randall Children's Hospital, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Се регрутираНабљудувачка студија
- Massive Bio SYNERGY-AI site, Portland
Observational Study of Iris Tumors
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Oregon Health & Science University, Portland
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Се регрутираФаза 1/2
- Oregon Health & Science University, Portland
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Се регрутира
- Kaiser Permanente Northwest - Oncology Clinic, Portland
Испитувања за Рак (сите типови) во други градови
- Houston, TX121 студија
- New York City, NY109 студии
- Boston, MA85 студии
- Los Angeles, CA74 студии
- Nashville, TN65 студии
- Philadelphia, PA59 студии
- Washington, DC58 студии
- Durham, NC58 студии
- Chicago, IL51 студија
- Atlanta, GA49 студии
- Seattle, WA49 студии
- Arlington, VA48 студии
Други студии во Portland
- Рак на бели дробови со не-мали клетки46 студии
- Рак на дојка33 студии
- Рак на простата33 студии
- Метастатски карцином29 студии
- Колоректален карцином28 студии
- Карцином на јајниците27 студии
- Рак на бели дробови26 студии
- Акутна миелоидна леукемија25 студии
- Рак на ендометриумот24 студии
- Сквамозноклеточен карцином на глава и врат19 студии
- Карцином на панкреасот19 студии
- Срцева слабост17 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.